These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2372570)

  • 1. Diagnostic ability of different human milk fat globule antigens in breast cancer.
    Ceriani RL; Blank EW; Rosenbaum EH; Ben Zeev D; Lowitz RS; Johansen L; Trujillo T
    Breast Cancer Res Treat; 1990 May; 15(3):161-74. PubMed ID: 2372570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating human mammary epithelial antigens in breast cancer.
    Ceriani RL; Sasaki M; Sussman H; Wara WM; Blank EW
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5420-4. PubMed ID: 6957872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mammary epithelial antigens (HME-Ags) in the circulation of nude mice implanted with a breast tumor and non-breast tumors.
    Sasaki M; Peterson JA; Wara WM; Ceriani RL
    Cancer; 1981 Nov; 48(10):2204-10. PubMed ID: 7296477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of human mammary epithelial antigens (HME-Ags) in breast cancer diagnosis.
    Ceriani RL; Orthendahl D; Sasaki M; Kaufman L; Miller S; Wara WM; Peterson JA
    Cancer Detect Prev; 1981; 4(1-4):603-9. PubMed ID: 7349827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
    Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
    Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel serum assay for breast epithelial antigen using a fusion protein.
    Ceriani RL; Larocca D; Peterson JA; Enloe S; Amiya R; Walkup G; Blank EW
    Anal Biochem; 1992 Feb; 201(1):178-84. PubMed ID: 1377884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
    Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
    Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer.
    Steger GG; Mader R; Derfler K; Moser K; Dittrich C
    Klin Wochenschr; 1989 Aug; 67(16):813-7. PubMed ID: 2796251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating proteinic biomarkers and breast cancer].
    Mathelin C; Koehl C; Rio MC
    Gynecol Obstet Fertil; 2006; 34(7-8):638-46. PubMed ID: 16876456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of circulating human mammary epithelial antigens (HME-Ags) as serum markers for breast cancer.
    Ceriani RL; Rosenbaum EH; Chandler M; Trujillo TT; Myers B; Sakada M
    Prog Clin Biol Res; 1986; 204():3-19. PubMed ID: 2421348
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer.
    Ogawa Y; Ishikawa T; Ikeda K; Nakata B; Sawada T; Ogisawa K; Kato Y; Hirakawa K
    Clin Cancer Res; 2000 Oct; 6(10):4069-72. PubMed ID: 11051258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer markers: comparison between sialyltransferase and human mammary epithelial antigens (HME-Ags) for the detection of human breast tumors grafted in nude mice.
    Sasaki M; Barber S; Ceriani RL
    Breast Cancer Res Treat; 1985; 5(1):51-6. PubMed ID: 3978247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.
    Suárez M; Pérez-Castejón MJ; Jiménez A; Domper M; Ruiz G; Montz R; Carreras JL
    Q J Nucl Med; 2002 Jun; 46(2):113-21. PubMed ID: 12114874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen.
    Daly L; Ferguson J; Cram GP; Hars V; George SL; McCarty KS; Bast RC
    J Clin Oncol; 1992 Jul; 10(7):1057-65. PubMed ID: 1607912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CA 549 and other associated antigens in breast cancer patients.
    Pavesi F; Lotzniker M; Scarabelli M; Mauro E; Visconti G; Nicolato E; Moratti R
    Oncology; 1994; 51(1):18-21. PubMed ID: 8265097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125.
    Fisken J; Roulston JE; Sturgeon C; Badley RA; Jönrup I; Aspinall L; Leonard RC
    Br J Cancer; 1993 May; 67(5):1065-70. PubMed ID: 8494699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and histological characterization of antigens preferentially expressed on the surface and cytoplasm of breast carcinoma cells identified by monoclonal antibodies against the human milk fat globule.
    Peterson JA; Zava DT; Duwe AK; Blank EW; Battifora H; Ceriani RL
    Hybridoma; 1990 Jun; 9(3):221-35. PubMed ID: 2365381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.